EC Healthcare
HKEX:2138
Cash Flow Statement
Cash Flow Statement
EC Healthcare
| Mar-2016 | Sep-2016 | Mar-2017 | Sep-2017 | Mar-2018 | Sep-2018 | Mar-2019 | Sep-2019 | Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||||
| Net Income |
184
|
0
|
245
|
0
|
330
|
0
|
450
|
0
|
361
|
0
|
266
|
0
|
321
|
0
|
136
|
0
|
17
|
0
|
(101)
|
0
|
|
| Depreciation & Amortization |
25
|
0
|
29
|
0
|
38
|
0
|
62
|
0
|
246
|
0
|
310
|
0
|
432
|
0
|
587
|
0
|
626
|
0
|
631
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
0
|
9
|
0
|
28
|
0
|
63
|
0
|
8
|
0
|
16
|
0
|
|
| Other Non-Cash Items |
1
|
0
|
(0)
|
0
|
(15)
|
0
|
5
|
0
|
21
|
0
|
19
|
0
|
57
|
0
|
136
|
0
|
144
|
0
|
167
|
0
|
|
| Cash Taxes Paid |
88
|
0
|
33
|
0
|
47
|
0
|
58
|
0
|
65
|
0
|
54
|
0
|
67
|
0
|
86
|
0
|
50
|
0
|
73
|
0
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
1
|
0
|
3
|
0
|
18
|
0
|
17
|
0
|
24
|
0
|
31
|
0
|
92
|
0
|
79
|
0
|
|
| Change in Working Capital |
(133)
|
(29)
|
(94)
|
280
|
(29)
|
317
|
(279)
|
327
|
(51)
|
573
|
27
|
760
|
(202)
|
392
|
(254)
|
729
|
(98)
|
793
|
47
|
607
|
|
| Cash from Operating Activities |
76
N/A
|
66
-14%
|
180
+174%
|
280
+56%
|
324
+16%
|
317
-2%
|
238
-25%
|
327
+37%
|
576
+76%
|
573
-1%
|
621
+8%
|
760
+22%
|
608
-20%
|
392
-36%
|
605
+54%
|
729
+20%
|
689
-5%
|
793
+15%
|
743
-6%
|
607
-18%
|
|
| Investing Cash Flow | |||||||||||||||||||||
| Capital Expenditures |
(29)
|
0
|
(50)
|
0
|
(52)
|
0
|
(287)
|
0
|
(70)
|
0
|
(149)
|
0
|
(260)
|
0
|
(412)
|
0
|
(161)
|
0
|
(57)
|
0
|
|
| Other Items |
(576)
|
(434)
|
(103)
|
(297)
|
(494)
|
(688)
|
270
|
466
|
386
|
(77)
|
(220)
|
(620)
|
(311)
|
(752)
|
(311)
|
(479)
|
(197)
|
(119)
|
398
|
60
|
|
| Cash from Investing Activities |
(605)
N/A
|
(455)
+25%
|
(153)
+66%
|
(297)
-94%
|
(545)
-83%
|
(688)
-26%
|
(17)
+98%
|
466
N/A
|
316
-32%
|
(77)
N/A
|
(369)
-381%
|
(620)
-68%
|
(571)
+8%
|
(752)
-32%
|
(724)
+4%
|
(479)
+34%
|
(358)
+25%
|
(119)
+67%
|
341
N/A
|
60
-82%
|
|
| Financing Cash Flow | |||||||||||||||||||||
| Net Issuance of Common Stock |
742
|
0
|
(90)
|
0
|
0
|
0
|
124
|
0
|
3
|
0
|
107
|
0
|
530
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
0
|
0
|
(0)
|
0
|
555
|
0
|
(16)
|
0
|
(383)
|
0
|
190
|
0
|
(555)
|
0
|
137
|
0
|
(126)
|
0
|
(422)
|
0
|
|
| Cash Paid for Dividends |
(60)
|
0
|
(90)
|
0
|
(240)
|
0
|
(290)
|
0
|
(345)
|
0
|
(114)
|
0
|
(272)
|
0
|
(118)
|
0
|
(56)
|
0
|
(12)
|
0
|
|
| Other |
71
|
(73)
|
(0)
|
(151)
|
(1)
|
293
|
34
|
(682)
|
(14)
|
(234)
|
(26)
|
657
|
197
|
(397)
|
(59)
|
(332)
|
(304)
|
(558)
|
(200)
|
(504)
|
|
| Cash from Financing Activities |
754
N/A
|
610
-19%
|
(180)
N/A
|
(151)
+16%
|
314
N/A
|
293
-7%
|
(149)
N/A
|
(682)
-358%
|
(739)
-8%
|
(234)
+68%
|
157
N/A
|
657
+319%
|
(100)
N/A
|
(397)
-297%
|
(40)
+90%
|
(332)
-727%
|
(486)
-47%
|
(558)
-15%
|
(634)
-14%
|
(504)
+20%
|
|
| Change in Cash | |||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
(1)
|
(1)
|
2
|
1
|
(1)
|
(1)
|
0
|
2
|
2
|
3
|
2
|
(4)
|
(2)
|
3
|
(1)
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
225
N/A
|
221
-2%
|
(154)
N/A
|
(169)
-10%
|
95
N/A
|
(77)
N/A
|
71
N/A
|
110
+54%
|
153
+40%
|
263
+72%
|
411
+56%
|
800
+95%
|
(61)
N/A
|
(762)
-1 152%
|
(160)
+79%
|
(79)
+51%
|
(156)
-98%
|
116
N/A
|
450
+289%
|
162
-64%
|
|
| Free Cash Flow | |||||||||||||||||||||
| Free Cash Flow |
48
N/A
|
66
+38%
|
130
+97%
|
280
+116%
|
272
-3%
|
317
+16%
|
(49)
N/A
|
327
N/A
|
507
+55%
|
573
+13%
|
472
-18%
|
760
+61%
|
348
-54%
|
392
+13%
|
193
-51%
|
729
+278%
|
528
-28%
|
793
+50%
|
686
-14%
|
607
-11%
|
|